Toxicity and infection at 1 year after transplantation
Effect . | All patients, n (%) . | BCC group, n (%) . | RCC group, n (%) . |
|---|---|---|---|
| Grades III-IV toxicity | |||
| Cardiac | 3 (13) | 1 (13) | 2 (13) |
| Pulmonary | 3 (13) | 0 | 3 (20) |
| Gastrointestinal | 9 (39) | 3 (38) | 6 (40) |
| Renal | 3 (13) | 0 | 3 (20) |
| Neurologic | 3 (13) | 0 | 3 (20) |
| Metabolic | 2 (9) | 1 (13) | 1 (7) |
| Fever/flulike symptoms | 7 (30) | 3 (38) | 4 (27) |
| Coagulopathy | 1 (4) | 0 | 1 (7) |
| Infection | |||
| Bacterial | 4 (17) | 2 (25) | 2 (13) |
| Fungal | 3 (13) | 1 (13) | 2 (13) |
| Acid-fast bacillus | 1 (4) | 0 | 1 (7) |
| Cytomegalovirus | 10 (43) | 5 (63) | 5 (33) |
| Herpes simplex/herpes zoster virus | 1 (4) | 1 (13) | 0 |
| Other virus | 3 (13) | 1 (13) | 2 (13) |
Effect . | All patients, n (%) . | BCC group, n (%) . | RCC group, n (%) . |
|---|---|---|---|
| Grades III-IV toxicity | |||
| Cardiac | 3 (13) | 1 (13) | 2 (13) |
| Pulmonary | 3 (13) | 0 | 3 (20) |
| Gastrointestinal | 9 (39) | 3 (38) | 6 (40) |
| Renal | 3 (13) | 0 | 3 (20) |
| Neurologic | 3 (13) | 0 | 3 (20) |
| Metabolic | 2 (9) | 1 (13) | 1 (7) |
| Fever/flulike symptoms | 7 (30) | 3 (38) | 4 (27) |
| Coagulopathy | 1 (4) | 0 | 1 (7) |
| Infection | |||
| Bacterial | 4 (17) | 2 (25) | 2 (13) |
| Fungal | 3 (13) | 1 (13) | 2 (13) |
| Acid-fast bacillus | 1 (4) | 0 | 1 (7) |
| Cytomegalovirus | 10 (43) | 5 (63) | 5 (33) |
| Herpes simplex/herpes zoster virus | 1 (4) | 1 (13) | 0 |
| Other virus | 3 (13) | 1 (13) | 2 (13) |
Values in the table are presented for all patients (n = 23), the BC group (n = 8), and the RCC group (n = 15).